$1.75
-0.06-3.31%
In chiusura: Nov 19, 4:00 PM EST
$2.00
0.2514.29%
Post-mercato: Nov 18, 7:57 PM EST

The average analyst price target for Atossa Therapeutics is $20.50, 925.0% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $12 to $25. The latest change came on Oct 1, 2026, when Ascendiant Capital raised its price target on Atossa Therapeutics from $24 to $25 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months